Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD
- PMID: 24643131
- PMCID: PMC4049264
- DOI: 10.1159/000360010
Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD
Abstract
Background: Intestinal microbiome constitutes a symbiotic ecosystem that is essential for health, and changes in its composition/function cause various illnesses. Biochemical milieu shapes the structure and function of the microbiome. Recently, we found marked differences in the abundance of numerous bacterial taxa between ESRD and healthy individuals. Influx of urea and uric acid and dietary restriction of fruits and vegetables to prevent hyperkalemia alter ESRD patients' intestinal milieu. We hypothesized that relative abundances of bacteria possessing urease, uricase, and p-cresol- and indole-producing enzymes is increased, while abundance of bacteria containing enzymes converting dietary fiber to short-chain fatty acids (SCFA) is reduced in ESRD.
Methods: Reference sets of bacteria containing genes of interest were compiled to family, and sets of intestinal bacterial families showing differential abundances between 12 healthy and 24 ESRD individuals enrolled in our original study were compiled. Overlap between sets was assessed using hypergeometric distribution tests.
Results: Among 19 microbial families that were dominant in ESRD patients, 12 possessed urease, 5 possessed uricase, and 4 possessed indole and p-cresol-forming enzymes. Among 4 microbial families that were diminished in ESRD patients, 2 possessed butyrate-forming enzymes. Probabilities of these overlapping distributions were <0.05.
Conclusions: ESRD patients exhibited significant expansion of bacterial families possessing urease, uricase, and indole and p-cresol forming enzymes, and contraction of families possessing butyrate-forming enzymes. Given the deleterious effects of indoxyl sulfate, p-cresol sulfate, and urea-derived ammonia, and beneficial actions of SCFA, these changes in intestinal microbial metabolism contribute to uremic toxicity and inflammation.
Similar articles
-
The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease.J Ren Nutr. 2022 Sep;32(5):578-586. doi: 10.1053/j.jrn.2021.09.007. Epub 2021 Nov 2. J Ren Nutr. 2022. PMID: 34736844
-
Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.Microbiome. 2016 Sep 17;4(1):50. doi: 10.1186/s40168-016-0195-9. Microbiome. 2016. PMID: 27640125 Free PMC article.
-
Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p-cresol sulfate.J Vet Intern Med. 2020 Jan;34(1):206-215. doi: 10.1111/jvim.15634. Epub 2019 Nov 6. J Vet Intern Med. 2020. PMID: 31693251 Free PMC article.
-
Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.Expert Rev Clin Pharmacol. 2018 Jan;11(1):71-82. doi: 10.1080/17512433.2018.1378095. Epub 2017 Sep 20. Expert Rev Clin Pharmacol. 2018. PMID: 28905671 Free PMC article. Review.
-
Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.Curr Diab Rep. 2017 Mar;17(3):16. doi: 10.1007/s11892-017-0841-z. Curr Diab Rep. 2017. PMID: 28271466 Review.
Cited by
-
The Administration of the Synbiotic Lactobacillus bulgaricus 6c3 Strain, Inulin and Fructooligosaccharide Decreases the Concentrations of Indoxyl Sulfate and Kidney Damage in a Rat Model.Toxins (Basel). 2021 Mar 7;13(3):192. doi: 10.3390/toxins13030192. Toxins (Basel). 2021. PMID: 33800029 Free PMC article.
-
Gut microbiota dysbiosis and protein energy wasting in patients on hemodialysis: an observational longitudinal study.Front Nutr. 2024 Jan 10;10:1270690. doi: 10.3389/fnut.2023.1270690. eCollection 2023. Front Nutr. 2024. PMID: 38268676 Free PMC article.
-
Causal relationship between gut microbiota and kidney diseases: a two-sample Mendelian randomization study.Front Immunol. 2024 Jan 12;14:1277554. doi: 10.3389/fimmu.2023.1277554. eCollection 2023. Front Immunol. 2024. PMID: 38283353 Free PMC article.
-
The Effects of Nutrition on the Gastrointestinal Microbiome of Cats and Dogs: Impact on Health and Disease.Front Microbiol. 2020 Jun 25;11:1266. doi: 10.3389/fmicb.2020.01266. eCollection 2020. Front Microbiol. 2020. PMID: 32670224 Free PMC article. Review.
-
Effects of end-stage renal disease and dialysis modalities on blood ammonia level.Hemodial Int. 2017 Jul;21(3):343-347. doi: 10.1111/hdi.12510. Epub 2016 Nov 1. Hemodial Int. 2017. PMID: 27804262 Free PMC article.
References
-
- Vaziri ND, Wong J, Pahl MV, et al. Chronic kidney disease alters the composition of intestinal microbial flora. Kidney Int. 2013;83:308–315. - PubMed
-
- Lee YT. Urea concentration in intestinal fluids in normal and uremic dogs. J Surg Oncol. 1971;3:163–168. - PubMed
-
- Swales JD, Tange JD, Evans DJ. Intestinal ammonia in uraemia: the effect of a urease inhibitor, acetohydroxamic acid. Clin Sci. 1972;42:105–112. - PubMed
-
- Kang JY. The gastrointestinal tract in uremia. Dig Dis Sci. 1993;38:257–268. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical